Effect of Glucose Degradation Products (GDP) on Endothelial Dysfunction
Status:
Completed
Trial end date:
2008-04-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the effects of neutral pH and low glucose
degradation product (GDP)-containing peritoneal dialysis fluid (PDF) on systemic inflammation
and endothelial dysfunction markers in incident PD patients.
Phase:
Phase 4
Details
Lead Sponsor:
Kyungpook National University Kyungpook National University Hospital
Collaborators:
Fresenius Medical Care Korea Ministry of Health & Welfare, Korea